ABBV vs C · P/E 81, rev $61.16B vs P/E 16, rev $85.22B
AbbVie Inc (ABBV) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the ABBV and C stock pages for the full models.
Not investment advice.